谷歌浏览器插件
订阅小程序
在清言上使用

P0800 : Effectiveness and Safety of Combination New Regimens Based on Sofosbuvir (SOFO) with Ribavirin (RBV), Daclatasvir (DAC) or Simeprevir (SIM) in Difficult Patients to Treat Infected with Chronic Hepatitis C (CHC)

JOURNAL OF HEPATOLOGY(2015)

引用 0|浏览46
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要